期刊文献+

多孔羟基磷灰石、纤维蛋白和金葡液复合物修复骨缺损的实验研究(英文) 被引量:1

Experimental study of coralline hydroxyapatite porous, fibrin sealant and staphylococcus aureus injection compound in bone defect restoration
下载PDF
导出
摘要 背景:骨缺损的修复一直是骨科治疗的难点,寻找有效修复骨缺损的骨移植替代材料是目前骨缺损治疗的研究方向。目的:探讨珊瑚多孔羟基磷灰石(corallinehydroxyapatiteporous,CHAP)、纤维蛋白(fibrinsealant,FS)及金葡液(staphylococcusaureusin-jection,SAI)复合物修复骨缺损的作用及其作为人工骨移植替代材料的可行性。设计:随机对照的试验研究。单位:中山大学附属第三医院骨科。材料:实验在中山大学动物实验室和解放军第一军医大学全军生物力学中心完成。羟基磷灰石,纤维蛋白,金葡液。方法:采用新西兰大白兔54只在兔双侧桡骨制备骨缺损模型后分成实验组、对照组及空白组。将CHAP-FS-SAI复合物植入骨缺损处作为实验组,以自体骨植入作为对照组,空白组不植入任何物质。在2,4,8和12周分别进行大体标本观察,组织学,X射线片观察及生物力学测试,比较各组修复骨缺损的能力。主要观察指标:动物一般情况,大体标本,X射线片,组织学,生物力学测定。结果:实验组术后2周见植入物与骨端形成紧密的纤维性连接,镜下可见CHAP周围大量成纤维细胞、软骨细胞及细胞钙化。12周实验组和对照组均见大量成熟的骨细胞及板层骨;实验组见植入物完全骨化,塑形完全,CHAP未完全降解。空白组12周骨缺损区为纤维瘢痕组织填充。 BACKGROUND:The restoration of bone defect is always difficult in the treatment of orthopaedics. To find an effective replacement material of bone transplantation to repair bone defect is the direction of the researches in bone defect therapy at present. OBJECTIVE:To investigate the effects of coralline hydroxyapatite porous(CHAP),fibrin sealant(FS) and staphylococcus aureus injection(SAI) compound in bone defect restoration and the feasibility of the compound to be used as replacement material in artificial bone transplantation. DESIGN:A randomized controlled trial. SETTING:Third Hospital affiliated to Sun Yat-sen University. MATERIALS:The study was accomplished in the Animal Laboratory of Sun Yat-sen University and the Institute of Biomechanics of First Military Medical University of Chinese PLA.Materials were CHAP,FS and SAI. METHODS:Fifty-four New Zealand rabbits were randomly divided into study group,control group and bone defect model group after the establishment of bone defect model in the radius on both sides.CHAP-FS-SAI compound was transplanted in the bone defect in rabbits of the study group and autologous bone was transplanted in the rabbits of the control group,nothing was transplanted in rabbits of bone defect model group.Gross specimens observation, histology,X-ray film observation and biomechanics test were conducted at 2,4,8 and 12 weeks respectively to compare the ability in bone defect restoration among each group. MAIN OUTCOME MEASURES:General condition, gross specimens,X-ray,histology,and biomechanical test RESULTS:At two weeks after operation,compact fibrous union between graft and bone end was formed in the study group. It could be seen under microscope that CHAP was surrounded by a lot of fibroblast,chondrocyte,and cellular calcification.At 12 weeks,quantities of mature osteoblasts and lamellar bones could be seen in both study group and control group.Graft in the study group was completely ossified with complete moulding but CHAP did not completely degrade.The bone defect area was filled with fibrous scarring tissue at 12 weeks in bone defect model group,in which most of them were fibroblasts under microscope.X-ray films: callus could be seen in both study group and control group at 2 weeks,which increased at 4 weeks.Bone defect disappeared at 8 weeks in the study group and CHAP scattered in the callus.Bone fracture line disappeared and the medullary cavity started to form in control group.Cortical bone was continuous and the medullary cavity re-connected at 12 weeks in both study group and control group with complete moulding. No osseous union was found in bone defect area at 12 weeks in bone defect model group.Biomechanical test:there were no significant differences in maximum torque and anti-torque stiffness at 4,8 and 12 weeks after operations between the study group and control group(P >0.05).However,at 2 weeks after operation,the maximum torque was(0.140±0.032) N.m in the study group,(0.105±0.035) N·m in the control group; the anti-torque stiffness was(0.401±0.050) N·m/rad in study group, which was significantly higher than(0.311±0.050) N·m/rad in control group(t=2.087 0,3.600 0,P< 0.05). CONCLUSION:CHAP-FS-SAI compound has relative powerful osteogenetic ability and favourable biocompatibility,which can be used as material to replace autologous bone transplantation in bone defect restoration.
出处 《中国临床康复》 CSCD 2004年第35期8119-8121,i006,共4页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献5

二级参考文献23

  • 1赵廷宝,范清宇,张殿忠,文艳华,何一成.骨形成蛋白在小白鼠体内诱导成骨的测定方法[J].中国实验动物学杂志,2001,11(1):47-49. 被引量:6
  • 2李亚非,胡蕴玉,李青,吕荣,王纪保,王军,韩一生,刘建,李雪冰,杨光.经皮注射骨形态发生蛋白和成纤维细胞生长因子促进兔骨缺损愈合[J].中华骨科杂志,1995,15(9):624-627. 被引量:24
  • 3徐寿香,张昭坤,沈百祥,谢旭明,王江.金葡液注射液生物测定的实验研究[J].中国新药杂志,1996,5(2):134-135. 被引量:7
  • 4Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Injury 2000; 31 (suppl 4): 37 - 47
  • 5Perry CR. Bone repair techniques, bone graft, and bone graft substitutes. Clin Orthop 1999; (360): 71 - 86
  • 6Bermudez. Optimization of a calcium orthophosphate cement formulation occuring in the combination of monocalcium phosphate monohydrate with calcium oxide. J Mater Sci Mater Med 1994; 5:67
  • 7Ney AL, Kelly PH, Tsukayama DT, et al. Fibrin glue-antibiotic suspension in the prevention of prosthetic graft infection. J Trauma 1990; 30(8): 1000 -6
  • 8Driessens FCM, Boltong MG, Bemudze O, et al. Formulation and setting times of some calcium orthophosphate cements: Apilot study. J Mater Sci Mater Med 1993; 4:503
  • 9Ginebra MP, Fernandez E, Boltong MG, et al. Compliance of an apatitic calciumphosphatecementwith the short-term clinical requirements inbone surgery,orthopaedics and dentisry. Clin Mater 1994; 17:99 - 104
  • 10Lacout JL, Mejdoub E, Hamad M. Crystallization mechanisms of calcium phosphate cement for biological uses. J Mater Sci Mater Med 1996; 7: 371

共引文献35

同被引文献9

  • 1Service RF. Tissue engineers build new bone. Science 2000; 289(5484):1498 -500
  • 2Constantz BR, Ison IC, Fulmer MT, et al. Skeletal repair by in situ formation of the mineral phydroxyapatitese of bone. Science 1995; 267 (5205 ) : 1796 - 9
  • 3Rehman I, Bonfield W. Chydroxyapatiteracterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy. J Mater Sci Mater Med 1997; 8(1): 1 -4
  • 4del Real RP, Ooms E, Wolke JG, et al. In vivo bone response to porous calcium phosphydroxyapatitete cement. J Biomed Mater Res A 2003; 65 ( 1 ) : 30 - 6
  • 5Ito A, Kawamura H, Miyakawa S, et al. Restorability and solubility of zinc-containing tricalcium phosphydroxyapatitete. J Biomed Mater Res 2002;60(2): 224 - 31
  • 6Manjubala I, Sivakumar M, Sureshkumar RV, et al. Bioactivity and osseointegration study of calcium phosphydroxyapatitete ceramic of different chemical composition. J Biomed Mater Res 2002; 63 (2) : 200 - 8
  • 7Baker SB, Weinzweig J, Kirschner RE, et al. Applications of a new carbonated calcium phosphydroxyapatitete bone cement: early experience in pediatric and adult craniofacial reconstruction. Plast Reconstr Surg 2002; 109 (6) : 1789 - 96
  • 8Goodman SB, Bauer TW, Carter D, et al. Norian SRS cement augmentation in hip fracture treatment. Laboratory and initial clinical results. Clin Orthop Relat Res 1998; (348):42-50
  • 9Cassidy C, Jupiter JB, Cohen M, et al. Norian SRS cement compared with conventional fixation in distal radial fractures. A randomized study. J Bone Joint Surg Am 2003; 85 - A (11 ): 2127 - 37

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部